Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Li Chung Shing Tong is a heritage pharmaceutical company based in Hong Kong, established in 1896 and renowned for its flagship product, Po Chai Pills. The company specializes in the development, manufacture, and global distribution of Traditional Chinese Medicine (TCM) focused on gastrointestinal health. In 2016, the company was acquired by Jacobson Pharma Corporation, Hong Kong's largest generic drug manufacturer, to serve as a cornerstone of its proprietary medicine division. Operating from the Po Chai Industrial Building in Wong Chuk Hang, the company utilizes GMP-certified facilities to maintain high quality standards for its herbal formulations. Its products are a staple in households across Asia and are exported to international markets including North America and Australia. The company continues to modernize its heritage brand while maintaining the traditional efficacy of its century-old recipes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Po Chai Industrial Building.